Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.137
-0.043 (-3.64%)
Nov 22, 2024, 4:00 PM EST - Market closed
Dermata Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2 | 2 | 5 | 14 | - | - |
| Market Cap Growth | -26.73% | -56.39% | -65.84% | - | - | - |
| Enterprise Value | -4 | -4 | -3 | 2 | - | - |
| Last Close Price | 1.14 | 9.15 | 98.16 | 417.60 | - | - |
| PB Ratio | 0.40 | 0.34 | 0.82 | 1.43 | - | - |
| P/TBV Ratio | 0.52 | 0.34 | 0.82 | 1.43 | - | - |
| Debt / Equity Ratio | - | - | - | - | -1.12 | -6.11 |
| Quick Ratio | 3.16 | 4.59 | 6.78 | 7.12 | 0.14 | 1.16 |
| Current Ratio | 3.44 | 4.91 | 7.53 | 7.66 | 0.16 | 1.20 |
| Return on Equity (ROE) | -202.20% | -125.96% | -119.18% | -228.09% | - | - |
| Return on Assets (ROA) | -102.89% | -67.36% | -65.13% | -80.31% | -148.47% | - |
| Return on Capital (ROIC) | -129.32% | -81.22% | -74.98% | -93.76% | -275.18% | - |
| Earnings Yield | -485.68% | -361.07% | -194.17% | -54.53% | - | - |
| FCF Yield | -404.93% | -296.87% | -178.48% | -39.29% | - | - |
| Buyback Yield / Dilution | -486.90% | -323.42% | -156.86% | - | - | - |
| Total Shareholder Return | -486.90% | -323.42% | -156.86% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.